Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1

被引:25
作者
de Mendoza, C
Rodriguez, C
Eiros, JM
Colomina, J
Garcia, F
Leiva, P
Torre-Cisneros, J
Aguero, J
Pedreira, J
Viciana, I
Corral, A
del Romero, J
de Lejarazu, RO
Soriano, V
机构
[1] Hosp Carlos III, Infect Dis Serv, Madrid, Spain
[2] Ctr Sanitario Sandoval, Madrid, Spain
[3] Hosp Clin, Microbiol Serv, Valladolid, Spain
[4] Hosp Ribera, Microbiol Serv, Valencia, Spain
[5] Hosp San Cecilio, Microbiol Serv, Granada, Spain
[6] Univ Oviedo, Hosp Cent Asturias, Microbiol Serv, E-33080 Oviedo, Spain
[7] Hosp Reina Sofia, Dept Internal Med, Cordoba, Spain
[8] Hosp Marques Valdecilla, Microbiol Serv, Santander, Spain
[9] Hosp Juan Canalejo, Dept Internal Med, La Coruna, Spain
[10] Hosp Virgen Victoria, Microbiol Serv, Malaga, Spain
关键词
D O I
10.1086/431203
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Human immunodeficiency virus (HIV) treatment guidelines have evolved, shifting from more-aggressive to more-conservative approaches. The potential impact of these shifts on the transmission of drug-resistant virus is unknown. Methods. Drug-resistance genotypes were examined in all consecutive patients with recent HIV type 1 (HIV1) seroconversion (hereafter, "HIV-1 seroconverters") seen at 10 Spanish hospitals since 1997. During the same period, the proportion of patients with chronic HIV-1 infection having undetectable viremia was examined, to estimate the extent and effectiveness of antiretroviral therapy. Results. A total of 141 recent HIV-1 seroconverters were identified, 67.4% of whom were men who have sex with men. The rate of primary drug-resistance mutations, by year of infection, was 33.3% for 1997, 29.4% for 1998, 20% for 1999, 14.3% for 2000, 3.4% for 2001, 15.4% for 2002, and 10.9% for 2003. On the other hand, the proportion of 8388 persons with chronic HIV-1 carriage who had an undetectable virus load was 33.4% for 1997, 34.6% for 1998, 39.7% for 1999, 47.5% for 2000, 52.9% for 2001, 39.7% for 2002, and 58.1% for 2003. A significant inverse correlation between transmission of drug-resistant HIV-1 and undetectable virus load was found (r = -0.955, by Spearman's test; P = .001). The lowest rate of transmission of drug-resistant HIV-1 was seen in 2001, when relatively " aggressive" treatment guidelines were used. Transmission of drug- resistant HIV-1 increased in 2002, in parallel with a reduction in the number of patients with chronic HIV-1 carriage and undetectable virus load, reflecting the popularity of drug holidays or treatment interruptions. Conclusion. The rate of drug resistance in recent HIV-1 seroconverters inversely correlates with the proportion of chronically HIV-1-infected individuals who have undetectable virus loads in the same region, which indirectly reflects antiretroviral treatment rules at any given time.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [1] Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load
    Arnaiz, JA
    Mallolas, J
    Podzamczer, D
    Gerstoft, J
    Lundgren, JD
    Cahn, P
    Fätkenheuer, G
    D'Arminio-Monforte, A
    Casiró, A
    Reiss, P
    Burger, DM
    Stek, M
    Gatell, JM
    [J]. AIDS, 2003, 17 (06) : 831 - 840
  • [2] Low rate of mother-to-child transmission of HIV-1 after nevirapine intervention in a pilot public health program in Yaounde, Cameroon
    Ayouba, A
    Tene, G
    Cunin, P
    Foupouapouognigni, Y
    Menu, E
    Kfutwah, A
    Thonnon, J
    Scarlatti, G
    Monny-Lobé, M
    Eteki, N
    Kouanfack, C
    Tardy, M
    Leke, R
    Nkam, M
    Nlend, AE
    Barré-Sinoussi, FO
    Martin, PMV
    Nerrienet, E
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (03) : 274 - 280
  • [3] Balotta C, 2001, J ACQ IMMUN DEF SYND, V27, P499, DOI 10.1097/00126334-200108150-00012
  • [4] BERTA B, 2004, AIDS, V18, P1109
  • [5] Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection
    Brenner, BG
    Routy, JP
    Petrella, M
    Moisi, D
    Oliveira, M
    Detorio, M
    Spira, B
    Essabag, V
    Conway, B
    Lalonde, R
    Sekaly, RP
    Wainberg, MA
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (04) : 1753 - 1761
  • [6] Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid
    Briones, C
    Pérez-Olmeda, M
    Rodríguez, C
    del Romero, J
    Hertogs, K
    Soriano, V
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (02) : 145 - 150
  • [7] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel
    Carpenter, CCJ
    Cooper, DA
    Fischl, MA
    Gatell, JM
    Gazzard, BG
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schechter, M
    Schooley, RT
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03): : 381 - 390
  • [8] Antiretroviral therapy for HIV infection in 1998 - Updated recommendations of the International AIDS Society USA panel
    Carpenter, CCJ
    Fischl, MA
    Hammer, SM
    Hirsch, MS
    Jacobsen, DM
    Katzenstein, DA
    Montaner, JSG
    Richman, DD
    Saag, MS
    Schooley, RT
    Thompson, MA
    Vella, S
    Yeni, PG
    Volberding, PA
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01): : 78 - 86
  • [9] Decline in the rate of genotypic resistance to antiretroviral drugs in recent HIV seroconverters in Madrid
    de Mendoza, C
    del Romero, J
    Rodríguez, C
    Corral, A
    Soriano, V
    [J]. AIDS, 2002, 16 (13) : 1830 - 1832
  • [10] de Mendoza Carmen, 2002, HIV Clin Trials, V3, P304